Allurion files PMA submission of Elipse Gastric Balloon with FDA
Allurion Technologies is one step closer to having its Elipse gastric balloon enter the US market, after company announced the PMA submission of the device to the FDA. The submission comes after Allurion raised US$34 million in new funding through a securities financing and a growth capital term loan.